Aurobindo Pharma Ltd share price: Shares of Aurobindo Pharma gained 2.9 per cent in trade, registering an intraday high at ₹1,222.9 on the BSE. The up move in the stock came after the company arm ...

Aurobindo Pharma Limited (APL), one of the ... As at June 13th of the year 2007 the Company unveiled their new Logo and Corporate Identity at a ceremony in Hyderabad. The new corporate logo ...

Bonus Mar 07, 2000 Apr 01, 2000 Feb 22, 2000 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Oct 26, 1998 Nov 19, 1998 Oct 08, 1998 Bonus Ratio: 1 share(s) for every 1 shares held Aurobindo ...

Aurobindo Pharma gained nearly 3% in trade on Wednesday, April 23, after it said its wholly-owned subsidiary, Eugia Pharma Specialities Limited, received the final approval from the US Food & Drug ...

Aurobindo Pharma made an announcement stating that its fully-owned subsidiary, Eugia Pharma Specialities Limited, has got final USFDA approval to make and sell Dasatinib Tablets in the US.

Shares of Indian pharma companies with significant US exposure surged by up to 14% after President Trump refrained from imposing new tariffs on the sector. While electronics and gems are hit by ...

With this, Aurobindo Pharma has now a total of 540 Abbreviated New Drug Application (ANDA) approvals from the USFDA — comprising 521 final approvals and 19 tentative ones. Aurobindo Pharma operates in ...

Hyderabad: Aurobindo Pharma Limited has announced that its wholly owned subsidiary, Eugia PharmaSpecialities Limited, has received final approval from the US Food & Drug Administration (USFDA) to ...

Aurobindo Pharma's subsidiary, Eugia Pharma Specialities Ltd, received USFDA approval for its generic Dasatinib tablets, used in treating certain bone marrow and blood cancers. The approval covers ...

Mirae Asset Large & Midcap Fund - Regular (G) 539.54 46,49,192 1.48 Mirae Asset Large & Midcap Fund - Regular (IDCW) 539.54 46,49,192 1.48 Mirae Asset Large & Midcap Fund - Direct (IDCW) 539.54 ...

Return on investment - most recent fiscal year 10.35 ...

Aurobindo Pharma Ltd ( (IN:AUROPHARMA)) has issued an announcement. Aurobindo Pharma Limited has received final approval from the USFDA to manufacture and market Rivaroxaban Tablets USP ...